These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 10453061
41. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis. Feith DJ, Shantz LM, Pegg AE. Cancer Res; 2001 Aug 15; 61(16):6073-81. PubMed ID: 11507056 [Abstract] [Full Text] [Related]
42. Intermittent 50 Hz magnetic field and skin tumor promotion in SENCAR mice. Rannug A, Holmberg B, Ekström T, Mild KH, Gimenez-Conti I, Slaga TJ. Carcinogenesis; 1994 Feb 15; 15(2):153-7. PubMed ID: 8313501 [Abstract] [Full Text] [Related]
43. DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue rats treated with 7, 12-dimethylbenz[a]anthracene. Manjanatha MG, Shelton SD, Culp SJ, Blankenship LR, Casciano DA. Carcinogenesis; 2000 Feb 15; 21(2):265-73. PubMed ID: 10657967 [Abstract] [Full Text] [Related]
44. Induction of cell proliferation, micronuclei and hyperdiploidy/polyploidy in the mammary cells of DDT- and DMBA-treated pubertal rats. Uppala PT, Roy SK, Tousson A, Barnes S, Uppala GR, Eastmond DA. Environ Mol Mutagen; 2005 Jul 15; 46(1):43-52. PubMed ID: 15880734 [Abstract] [Full Text] [Related]
45. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea. VanderPloeg LC, Wolfrom DM, Welsch CW. Cancer Res; 1991 Jul 01; 51(13):3399-404. PubMed ID: 1905195 [Abstract] [Full Text] [Related]
46. Animal studies on the role of 50/60-Hertz magnetic fields in carcinogenesis. Löscher W, Mevissen M. Life Sci; 1994 Jul 01; 54(21):1531-43. PubMed ID: 8196474 [Abstract] [Full Text] [Related]
47. Effects of 50 Hz magnetic fields on UV-induced skin tumourigenesis in ODC-transgenic and non-transgenic mice. Kumlin T, Kosma VM, Alhonen L, Jänne J, Komulainen H, Lang S, Rytömaa T, Servomaa K, Juutilainen J. Int J Radiat Biol; 1998 Jan 01; 73(1):113-21. PubMed ID: 9464483 [Abstract] [Full Text] [Related]
48. Prolactin stimulation of ornithine decarboxylase activity in the mammary gland may involve an activation of protein kinase C. Rillema JA. Proc Soc Exp Biol Med; 1985 Mar 01; 178(3):490-4. PubMed ID: 3156383 [Abstract] [Full Text] [Related]
49. 7,12-Dimethylbenz[a]anthracene/12-O-tetradecanoyl-phorbol-13-acetate-mediated skin tumor initiation and promotion in male Sprague-Dawley rats. Schweizer J, Loehrke H, Hesse B, Goerttler K. Carcinogenesis; 1982 Mar 01; 3(7):785-9. PubMed ID: 6811148 [Abstract] [Full Text] [Related]
50. Inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes. Bomser J, Singletary K, Meline B. Chem Biol Interact; 2000 Jun 15; 127(1):45-59. PubMed ID: 10903418 [Abstract] [Full Text] [Related]
51. Effect of constant light on DMBA mammary tumorigenesis in rats. Anderson LE, Morris JE, Sasser LB, Stevens RG. Cancer Lett; 2000 Feb 01; 148(2):121-6. PubMed ID: 10695987 [Abstract] [Full Text] [Related]
52. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin. Perchellet JP, Abney NL, Thomas RM, Guislain YL, Perchellet EM. Cancer Res; 1987 Jan 15; 47(2):477-85. PubMed ID: 3098411 [Abstract] [Full Text] [Related]
53. Haploinsufficiency for odc modifies mouse skin tumor susceptibility. Guo Y, Cleveland JL, O'Brien TG. Cancer Res; 2005 Feb 15; 65(4):1146-9. PubMed ID: 15734996 [Abstract] [Full Text] [Related]
54. Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen 7,12-dimethylbenz[a]anthracene. Manjanatha MG, Lyn-Cook LE, Culp SJ, Beland FA, Heflich RH, Aidoo A. Mutat Res; 1996 Oct 25; 357(1-2):89-96. PubMed ID: 8876684 [Abstract] [Full Text] [Related]
55. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene. Arif JM, Smith WA, Gupta RC. Mutat Res; 1997 Aug 01; 378(1-2):31-9. PubMed ID: 9288883 [Abstract] [Full Text] [Related]
56. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta. Kang JS, Kim S, Che JH, Nam KT, Kim DJ, Jang DD, Yang KH. Oncol Rep; 2004 Oct 01; 12(4):689-93. PubMed ID: 15375486 [Abstract] [Full Text] [Related]
57. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression. Wheeler DL, Reddig PJ, Dreckschmidt NE, Leitges M, Verma AK. Oncogene; 2002 May 16; 21(22):3620-30. PubMed ID: 12032864 [Abstract] [Full Text] [Related]
58. Protective effect of Ocimum sanctum on 3-methylcholanthrene, 7,12-dimethylbenz(a)anthracene and aflatoxin B1 induced skin tumorigenesis in mice. Rastogi S, Shukla Y, Paul BN, Chowdhuri DK, Khanna SK, Das M. Toxicol Appl Pharmacol; 2007 Nov 01; 224(3):228-40. PubMed ID: 17669454 [Abstract] [Full Text] [Related]
59. Presence of a functionally altered ornithine decarboxylase activity in chrysarobin-promoted mouse epidermal papillomas. O'Brien TG, O'Donnell K, Kruszewski FH, DiGiovanni J. Carcinogenesis; 1988 Nov 01; 9(11):2081-5. PubMed ID: 3141077 [Abstract] [Full Text] [Related]
60. The superposition of a temporally incoherent magnetic field inhibits 60 Hz-induced changes in the ODC activity of developing chick embryos. Farrell JM, Barber M, Krause D, Litovitz TA. Bioelectromagnetics; 1998 Nov 01; 19(1):53-6. PubMed ID: 9453707 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]